Targeted disruption of the dopamine D2 and D3 receptor genes leads to different alterations in the expression of striatal Calbindin-D(28k)

Neuroscience

Volumn 97, Issue 3, 2000, Pages 495-504

  Jung, M Y ^a   Hof, P R ^b   Schmauss, C ^a  

^a Och Spine at New York Presbyterian Hospitals   (United States)

^b Kastor Neurbio Aging Labs F   (United States)

Author keywords

Acetylcholinesterase; Calbindin; D2 like dopamine receptors; Gene targeting; Striatum; Tyrosine hydroxylase

Indexed keywords

ACETYLCHOLINESTERASE; CALBINDIN; DOPAMINE 2 RECEPTOR; DOPAMINE 3 RECEPTOR; TYROSINE 3 MONOOXYGENASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY LABELING; ARTICLE; CELLULAR DISTRIBUTION; CORPUS STRIATUM; GENE DISRUPTION; GENE EXPRESSION; GENE TARGETING; IMMUNOBLOTTING; IMMUNOCYTOCHEMISTRY; IMMUNOREACTIVITY; MOUSE; MUTANT; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ACETYLCHOLINESTERASE; ANIMALS; CALCIUM-BINDING PROTEIN, VITAMIN D-DEPENDENT; FEMALE; MALE; MICE; MICE, KNOCKOUT; NEOSTRIATUM; NEURONS; RECEPTORS, DOPAMINE D2; RECEPTORS, DOPAMINE D3; TYROSINE 3-MONOOXYGENASE;

EID: 0034035983     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-4522(00)00027-0     Document Type: Article

References (25)

1. Accili D., Fishburn C.S., Drago J., Steiner H., Lachowicz J.E., Park B.-H., Gauda E.B., Lee E.J., Cool M.H., Sibley D.R., Gerfen C.R., Westphal H., Fuchs S. A targeted mutation of the D3 dopamine receptor gene is associated with hyperactivity in mice. Proc. natn. Acad. Sci. U.S.A. 93:1996;1945-1949.
2. Airaksinen M.S., Eilers J., Garaschuk O., Thoenen H., Konnerth A., Meyer M. Ataxia and altered dendritic calcium signaling in mice carrying a targeted null mutation of the calbindin D28K gene. Proc. natn. Acad. Sci. U.S.A. 94:1997;1488-1493.
3. Baik J.-H., Picetti R., Dalardi A., Thirlet G., Dierich A., Depaulis A., Le Meur M., Borelli E. Parkinsonian-like locomotor impairment in mice lacking dopamine D2 receptors. Nature. 377:1995;424-428.
4. Baimbridge K.G., Celio M.R., Rogers J.H. Calcium-binding proteins in the nervous system. Trends Neurosci. 15:1992;303-308.
5. Calabresi P., Saiardi A., Pisani A., Baik J.-H., Centonze D., Mercuri N.B., Bernadi G., Borreli E. Abnormal synaptic plasticity in the striatum of mice lacking dopamine D2 receptors. J. Neurosci. 17:1997;4536-4544.
6. Demotes-Mainard J., Henry C., Jeantet Y., Arsaut J., Arnauld E. Postnatal ontogeny of dopamine D3 receptors in the mouse brain: autoradiographic evidence for a transient cortical expression. Devl Brain Res. 94:1996;166-174.
7. Diaz J., Ridray S., Mignon V., Griffon N., Schwartz J.-C., Sokoloff P. Selective expression of dopamine D3 receptor mRNA in proliferative zones during embryonic development of the rat brain. J. Neurosci. 17:1997;4282-4292.
8. DiFiglia M., Christakos S., Aronin N. Ultrastructural localization of immunoreactive calbindin-D28K in the rat and monkey basal ganglia, including subcellular distribution within colloidal gold labeling. J. comp. Neurol. 279:1989;653-665.
9. Drago J., Gerfen C.R., Lachowicz J.E., Steiner H., Hollon T.R., Love P.E., Ooi G.T., Grinberg A., Lee E.J., Huang S.P., Bartlett P.F., Jose P.A., Sibley D.R., Westphal H. Altered striatal function in a mutant mouse lacking D1A dopamine receptors. Proc. natn. Acad. Sci. U.S.A. 91:1994;12,564-12,568.
10. Gerfen C.R., Baimbridge K.G., Miller J.J. The neostriatal mosaic: compartmental distribution of calcium-binding protein and parvalbumin in the basal ganglia of the rat and monkey. Proc. natn. Acad. Sci. U.S.A. 82:1985;8780-8784.
11. Graybiel A.M., Pickel V.M., Joh T.H., Reis D.J., Ragsdale C.W. Jr. Direct demonstration of a correspondence between the dopamine islands and acetylcholinesterase patches in the developing striatum. Proc. natn. Acad. Sci. U.S.A. 78:1981;5871-5875.
12. Graybiel A.M. Correspondence between the dopamine islands and striosomes of the mammalian striatum. Neuroscience. 13:1984;1157-1187.
13. Jung M.-Y., Skryabin B.V., Arai M., Abbondanzo S., Fu D., Brosius J., Robakis N.K., Polites H.G., Pintar J.E., Schmauss C. Potentiation of the D2-mutant motor phenotype in mice lacking dopamine D2 and D3 receptors. Neuroscience. 91:1999;911-924.
14. Köhr G., Lambert C.E., Mody I. Calbindin-D28K (CaBP) levels and calcium currents in acutely dissociated epileptic neurons. Expl Brain Res. 85:1991;543-551.
15. Levant B. The D3 dopamine receptor: neurobiology and potential clinical relevance. Pharmac. Rev. 49:1997;231-252.
16. Liu F.-C., Graybiel A.M. Transient calbindin-D28K-positive systems in the telencephalon: ganglionic eminence, developing striatum and cerebral cortex. J. Neurosci. 12:1992;674-690.
17. Liu F.-C., Graybiel A.M. Heterogeneous development of calbindin-D28K expression in the striatal matrix. J. comp. Neurol. 320:1992;304-322.
18. Missale C., Nash S.R., Robinson S.W., Jaber M., Caron M.G. Dopamine receptors: from structure to function. Physiol. Rev. 78:1998;189-225.
19. Nägerl U.V., Mody I. Calcium-dependent inactivation of high-threshold calcium currents in human dentate gyrus granule cells. J. Physiol. 509:1998;39-45.
20. 125I]iodosulpiride. Neuroscience. 28:1988;673-700.
21. Schambra U.B., Duncan G.E., Breese G.R., Fornaretto M.G., Caron M.G., Fremeau R.T. Jr. Ontogeny of D1A and D2 dopamine receptor subtypes in rat brain using in situ hybridization and receptor binding. Neuroscience. 62:1994;65-85.
22. Sibley D.R. New insight into dopaminergic receptor function using antisense and genetically altered animals. A. Rev. Pharmac. Toxic. 39:1999;313-341.
23. Woolf N.J., Butcher L.L. Cholinergic neurons in the caudate-putamen complex proper are intrinsically organized: a combined Evans Blue and acetylcholinesterase analysis. Brain Res. Bull. 7:1981;487-507.
24. Xu M., Moratalla R., Gold L.H., Hiroi N., Koob G.F., Graybiel A.M., Tonegawa S. Dopamine D1 receptor mutant mice are deficient in striatal expression of dynorphin and in dopamine-mediated behavioral responses. Cell. 79:1994;729-742.
25. Xu M., Koeltzow T.E., Santiago G.T., Moratalla R., Cooper D.C., Hu X.-T., White N.M., Graybiel A.M., White F.J., Tonegawa S. Dopamine D3 receptor mutant mice exhibit increased behavioral sensitivity to concurrent stimulation of D1 and D2 receptors. Neuron. 19:1997;837-848.